Given that the risk factors for all-cause mortality among the four poor outcomes were relatively well established, to verify the methodological error of the Cox analysis for the results in Table 4 results, we performed univariable and multivariable Cox proportional hazards analyses including traditional, AAV-specific, and inflammation-related risk factors along with GPX-3 concentration at diagnosis for all-cause mortality during follow-up (Supplementary Table S1)
Other Important Safety Information Do not use B12/MIC if you are currently pregnant, breastfeeding or plan to become pregnant or breastfeed
Evolving Concepts in Insulin Resistance
We collected the following baseline demographic and clinical data: age, sex, smoking history, symptoms, comorbidities, respiratory support level (type and fraction of inspired oxygen, FiO 2 ), PaO 2 /FiO 2 (PFO), hematological and biochemical parameters findings, Chest CT images, other treatments reflecting the standard of care in use during the time of the trial, including the use of any prophylactic or therapeutic anti-coagulant treatment, intravenous corticosteroids
